Study | Number of subjects | number of coronary artery lesions | Patient (No.) | Age at inclusion | Coronary artery damage manifestation | Treatment | Coronary recovery time |
---|---|---|---|---|---|---|---|
Gonca Keskindemirci | 1 | 1 | 1 | 2 years | Left coronary artery dilatation(z score:3.23),Left anterior descending artery dilatation(z score:4.83) | Methotrexate,Steroid, Anakinra,Cyclosporin, Prednisolon | 6 months |
Shakeel Shaikh | 1 | 1 | 1 | 6 years | right coronary artery dilatation(5.7 - 6.2 mm) with Thrombus formation | Methylprednisolone | 2 weeks |
Alain Lefèvre-Utile | 29 | 4 | 1 | 10 months | Left coronary artery dilatation of 3 mm, a pericardial effusion | High doses of systemic steroids, MTX,Etanercept, Canakinumab,Roactemra | 3 months |
2 | 14 months | Pericardial effusion (5,6 mm) and hyperechogenicity with irregularity of the left coronary artery | High doses of systemic steroids | 1 week for the artery dilatation and 1 month for pericarditis | |||
3 | 2 years | Thickened left coronary artery walls | High doses of systemic steroids, Tocilizumab | 1 week | |||
4 | 14 years | a hyperechogenicity of the left and right arteries | High doses of systemic steroids, Anakinra | 2 weeks | |||
Bryce A.Binstadt | 12 | 5 | 1 | 4 years | Left coronary artery dilatation(z score:3.19),Left anterior descending artery dilatation(z score:2.47) | Methotrexate | 4 months |
2 | 6 years | Right coronary artery dilatation(z score:3.18) | Methotrexate, Infliximab | 5 Days | |||
3 | 2 years | Right coronary artery dilatation(z score:2.53) | Methotrexate, Naproxen | 5 Days | |||
4 | 1 year | Left anterior descending artery dilatation (z score:2.2),Right coronary artery dilatation(z score:2.08) | Methotrexate, Prednisolone, Etanercept, Thalidomide, Methylprednisolone | 1 month | |||
5 | 10 years | Left anterior descending artery dilatation (z score:2.18) | Methotrexate, Hydroxychloroquine | 1 month | |||
Sharath Kumar | 1 | 1 | 1 | 6 years | Right coronary artery dilatation(2.7 mm),Left coronary artery dilatation(3.3 mm), | Methylprednisolone, Cyclosporine, Etoposide,Dexamethasone | 2 weeks |
Li SN | 5 | 5 | 1 | 7 months to 4 years and 7 months | Unilateral coronary artery dilation | Methylprednisolone,Methotrexate | 1-3 months |
2 | Unilateral coronary artery dilation | Methylprednisolone,Methotrexate | |||||
3 | Unilateral coronary artery dilation | Methylprednisolone, Cyclosporine,Tocilizumab,Methotrexate, | |||||
4 | Bilateral coronary artery dilation | Methylprednisolone, Cyclosporine,Tocilizumab,Methotrexate, | |||||
5 | Bilateral coronary artery dilation | Methylprednisolone, Cyclosporine,Tocilizumab, Methotrexate | |||||
A. Felix | 25 | 4 | 1 | 3.8 years | Coronary artery dilation(3.6 mm) | MTX,Anakinra,Roactemra, Methylprednisolone | 2 months |
2 | 4.4 years | Coronary artery dilation(3.4 mm) | Methylprednisolone | 2 months | |||
3 | 7 years | Coronary artery dilation(5.2 mm) | Methylprednisolone | 2 months | |||
4 | 14.3 years | Coronary artery dilation(4.2 mm) | Anakinra, MethylpredNisolone | 2 months |